Brimopress Eye Drop
Brimopress Eye Drop is for external use only. Use it in the dose and duration as advised by the doctor. If you wear contact lenses, remove them before using the medication. Avoid touching the tip of the dropper to any surface as it may contaminate the eye drop. For best results, use it daily in the evening or at night.
Brimopress Eye Drop
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Brimopress Eye Drop is used in the treatment of ocular hypertension (pressure in the eye) and glaucoma. It helps to lower high pressure in the eye and reduces the risk of vision loss. This medicine may be used alone or in combination with another eye drop that reduces pressure in the eye.
Brimopress Eye Drop is for external use only. Use it in the dose and duration as advised by the doctor. If you wear contact lenses, remove them before using the medication. Avoid touching the tip of the dropper to any surface as it may contaminate the eye drop. For best results, use it daily in the evening or at night.
The common side effects include allergic conjunctivitis, burning sensation, conjunctival inflammation, conjunctival hyperemia, eye itching, high blood pressure, allergic reaction in the eyes, dry mouth, and visual disturbance. If they persist or worsen, inform your doctor. If these side effects persist for a longer duration, please inform your doctor. Caution is advised for driving after administration of this injection if your eyes are not able to concentrate and react.
03Uses
Ocular hypertension
Glaucoma
04How To Use
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
05How It Works
Brimopress Eye Drop is a sympathomimetic. It works by decreasing the production of aqueous humour (fluid in the eye), thereby lowering the increased eye pressure.
06What If You Miss A Dose?
If you miss a dose of Brimopress Eye Drop, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Ocular hypertension
Ocular hypertension is a condition where the pressure inside the eye is higher than normal eye pressure. This may occur due to an injury, certain diseases or as an adverse effect of certain medications. Brimopress Eye Drop reduces the fluid accumulation of the eye and facilitates draining of the fluid from the eyes. This helps treat ocular hypertension and prevents further damage or complications such as vision changes or even vision loss.
In Glaucoma
Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for good vision. This damage is often caused by an abnormally high pressure in your eye. Glaucoma is one of the leading causes of blindness for people over the age of 60 or older. Brimopress Eye Drop is used to reduce swelling and pressure inside the eye. This helps to prevent complications of glaucoma such as blindness and improves the vision.show moreshow less
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
High blood pressure
Burning sensation
Allergic conjunctivitis
Dryness in mouth
Follicular conjunctivitis
Conjunctival hyperemia
Allergic reaction in eye
Eye itching
09Safety Information
Alcohol:
No interaction found/established
Pregnancy:SAFE IF PRESCRIBED
Brimopress Eye Drop is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding:SAFE IF PRESCRIBED
Brimopress Eye Drop is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.To reduce the amount of Brimopress Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Driving:UNSAFE
Brimopress Eye Drop may cause side effects which could affect your ability to drive.Brimopress Eye Drop may cause blurred or abnormal vision. This effect may seem worse at night or in reduced lighting and this may affect the ability to drive.
Kidney:
No interaction found/established
Liver:
No interaction found/established
10Drug Tips
Brimopress Eye Drop helps lower high pressure in the eye and reduces the risk of vision loss.
For best results, put one drop 2-3 times daily in the affected eye(s).
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
Remove contact lenses before using Brimopress Eye Drop and allow at least 15 minutes before re-inserting them.
Do not touch the tip of the dropper to any surface, or to your eye, to avoid contaminating the eye drops.
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
It may cause short term blurring of vision when first used. Use caution before driving or using machines.
It may cause temporary burning or itching sensation in the eye. Inform your doctor if this does not go away.
Make sure to use within 4 weeks of opening the bottle.
References
Sources and references
Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 297.
Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 144.
Brimonidine tartrate. Fareham, Hampshire: FDC International Ltd.; 2010 . view
Brimonidine. Irvine, California: Allergan, Inc.; 1996 . view
Central Drugs Standard Control Organisation . view
